Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-25-011084
Filing Date
2025-03-21
Accepted
2025-03-21 08:20:28
Documents
76
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1912433
2 ex19-1.htm EX-19.1 125999
3 ex21-1.htm EX-21.1 6085
4 ex23-1.htm EX-23.1 4897
5 ex31-1.htm EX-31.1 12773
6 ex32-1.htm EX-32.1 7917
  Complete submission text file 0001493152-25-011084.txt   6409706

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE pulm-20241231.xsd EX-101.SCH 43580
8 XBRL CALCULATION FILE pulm-20241231_cal.xml EX-101.CAL 61903
9 XBRL DEFINITION FILE pulm-20241231_def.xml EX-101.DEF 155127
10 XBRL LABEL FILE pulm-20241231_lab.xml EX-101.LAB 401563
11 XBRL PRESENTATION FILE pulm-20241231_pre.xml EX-101.PRE 303570
78 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 665953
Mailing Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701
Business Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701 (888) 355-4440
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36199 | Film No.: 25758592
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)